Search

everythinglearnresearchcommunity

for

Search:↓

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Dutasteride injections can help hair growth in androgenic alopecia but need more research for long-term use.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

The Shen Bai Hair Growing Decoction may help treat hair loss by promoting hair growth and reducing inflammation.

High doses of finasteride cause cell growth and tumors in mice.

Finasteride causes abnormal growth in male mice cells at high doses.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Spironolactone works well for acne and hirsutism, isotretinoin is very effective for acne and may have antiandrogenic effects, and 5 alpha-reductase inhibitors should be considered antiandrogens.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

Ketogenic diet, neurosteroids, and HMGB1-TLR4 signaling pathway are potential targets for new epilepsy treatments.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.